SHENZHEN,China,March 17,2025--MicroCloud Hologram Inc. (NASDAQ: HOLO),("HOLO" or the "Company"),a technology service provider,they are researching CV-QNN (Continuous Variable Quant
TORONTO,March 17,2025-- Visionary Holdings Inc (NASDAQ: GV,hereinafter referred to as "Visionary") has made a significant announcement. The company has taken a milestone and crucial step in
HONG KONG,March 18,2025-- China Merchants Commercial Real Estate Investment Trust ("CMC REIT" or "the Trust",HKEX stock code:1503),announced its annual results for the year ended 3
XI\'AN,China,March 18,2025-- From March 11th to 13th,the largest photovoltaic exhibition in the Netherlands,Solar Solutions Amsterdam (SSA),was grandly held in Amsterdam. As a globally leading solar
TOKYO,March 18,2025--The Global Health Innovative Technology (GHIT) Fundannounced today a total investment of approximately JPY 1.7 billion (USD 11.4 million1) in five projects for the development of
SAN JOSE,Calif.,March 18,2025-- DeepRoute.ai,a pioneer in developing and deploying end-to-end smart driving solutions,unveiled AI Spark platform to build an AI-driven "road brain" system to
SINGAPORE,Feb. 5,2025--The KOREA INNOVATION FOUNDATION (INNOPOLIS) – an R&D Innovation Cluster Of The Republic Of Korea has at participated in SWITCH 2024 (Singapore) – the largest tech event in
JAKARTA,Indonesia,Feb. 5,2025-- As global business communities place greater emphasis on sustainability,the potential of ASEAN\'s blue economy offers a renewed opportunity for forward-thinking busines
Azbil\'s initiatives reinforce its commitment to exceeding customer expectations,solidifying its reputation as a leader in automation technology and positioning it for continued success and innovation
KUALA LUMPUR,Malaysia,Jan. 21,2025-- TheAISSE 2025 will take place from January 20 to 22,2025,at the Putrajaya International Convention Centre (PICC),and Chery is proud to be the event\'s Official VIP
SINGAPORE,Jan. 21,2025-- The Marketing Society proudly announces key leadership updates within its Singapore hub as the organisation continues to strengthen its commitment to empower marketers to thr
ASC30 oral tablet demonstrated dose-proportional pharmacokinetic (PK) properties and a long half-life (t1/2) up to 60 hours in the single ascending dose (SAD) study of patients with obesity,supporting